Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Therapeutic Reversal of Peripheral Olfactory Impairment in Bardet-Biedl Syndrome.

Molecular therapy : the journal of the American Society of Gene Therapy - 5 Apr 2017

Williams Corey L, Uytingco Cedric R, Green Warren W, McIntyre Jeremy C, Ukhanov Kirill, Zimmerman Arthur D, Shively Dana T, Zhang Lian, Nishimura Darryl Y, Sheffield Val C, Martens Jeffrey R

Abstract excerpt

Olfactory dysfunction is a pervasive but underappreciated health concern that affects personal safety and quality of life. Patients with olfactory dysfunctions have limited therapeutic options, particularly those involving congenital diseases. Bardet-Biedl syndrome (BBS) is one such disorder, where olfactory loss and other symptoms manifest from defective cilium morphology and/or function in various cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bardet-Biedl Syndrome
Share to Cilia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dependovirus

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Microtubule-Associated Proteins

Share to Olfactory Receptor Neurons

Share to Transduction, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 28237838
DOI: 10.1016/j.ymthe.2017.02.006
PMCID: PMC5383630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Therapeutic Reversal of Peripheral Olfactory Impairment in Bardet-Biedl Syndrome.PMID 28237838Read ↗

Gene therapy rescues olfactory perception in a clinically relevant ciliopathy model of Bardet-Biedl syndrome.Semantic proximity Read ↗

BBSome function is required for both the morphogenesis and maintenance of the photoreceptor outer segment.Semantic proximity Read ↗

Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy.Semantic proximity Read ↗

A <i>Bbs5</i> mouse model reveals pituitary cilia contributions to developmental abnormalitiesSemantic proximity Read ↗

Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse.Semantic proximity Read ↗

A mouse model of BBS identifies developmental and homeostatic effects of BBS5 mutation and identifies novel pituitary abnormalities.Semantic proximity Read ↗

Olfactory Loss and Dysfunction in Ciliopathies: Molecular Mechanisms and Potential TherapiesSemantic proximity Read ↗

Bardet-Biedl syndrome: Is it only cilia dysfunction?Semantic proximity Read ↗

A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity.Semantic proximity Read ↗

Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly.Semantic proximity Read ↗

Ectopic expression of BBS1 rescues male infertility, but not retinal degeneration, in a BBS1 mouse model.Semantic proximity Read ↗

ciBAR1 loss in mice causes laterality defects, pancreatic degeneration, and altered glucose tolerance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.